MedPath

Korean Red Ginseng and Metabolic Syndrome

Not Applicable
Completed
Conditions
Metabolic Syndrome
Interventions
Dietary Supplement: starch
Dietary Supplement: Korean red ginseng
Registration Number
NCT00976274
Lead Sponsor
The Korean Society of Ginseng
Brief Summary

Five factor consisting of Metabolic syndrome is closely linked by insulin resistance. Until now, several studies have been performed about effects of Korea red ginseng on hypertension, diabetes, and hyperlipidemia, but not metabolic syndrome.

The investigators hypothesize that Korean red ginseng could improve each constituents of metabolic syndrome, arterial stiffness, and inflammatory markers.

The aim of this study is to determine effects of Korean red ginseng on cardiovascular risks in subjects with metabolic syndrome.

Detailed Description

The details of study objective are followed by these:

* comparison of blood pressure before and after Korean red ginseng administration

* comparison of metabolic indicator before and after Korean red ginseng administration

* comparison of oxidative stress and inflammatory markers before and after Korean red ginseng administration

* comparison of arterial stiffness before and after Korean red ginseng administration

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria

(three or more of following five factors)

  • waist circumference(male: more than 90cm, female: more than 80cm)
  • blood pressure(systolic: more than 130mmHg, diastolic: more than 85mmHg)
  • fasting plasma glucose: more than 100mg/dL
  • fasting triglycerides: more than 150mg/dL
  • High-density lipoprotein(HDL)-cholesterol(male: less than 40mg/dL, female: less than 50mg/dL)
Exclusion Criteria

(any one of following factors)

  • uncontrolled blood pressure(systolic: more than 160mmHg, diastolic: more than 100mmHg) or subjects taking blood pressure lowering drug
  • Type 2 diabetes patients or fasting plasma glucose more than 126mg/dL
  • triglyceride more than 400mg/dL, total cholesterol more than 250mg/dL
  • subjects taking antilipidemic drug
  • past history of coronary heart disease or cerebrovascular disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
starch capsulestarch-
Korea red ginsengKorean red ginseng-
Primary Outcome Measures
NameTimeMethod
Change in the Pre- and Post-treatment Systolic Blood Pressurebaseline and 12 weeks
Secondary Outcome Measures
NameTimeMethod
Change in the Pre- and Post-treatment Oxidized Low-densty Lipoprotein(LDL)baseline and 12 weeks

Trial Locations

Locations (1)

Yonsei Univeristy College of Medicine, Gangnam Severance Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath